139 related articles for article (PubMed ID: 31485537)
1. Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor
Hadni H; Elhallaoui M
Heliyon; 2019 Aug; 5(8):e02357. PubMed ID: 31485537
[No Abstract] [Full Text] [Related]
2. Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types.
Hadni H; Mazigh M; Charif E; Bouayad A; Elhallaoui M
Biochem Res Int; 2018; 2018():8639173. PubMed ID: 30034881
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR, molecular docking, DFT and ADMET studies on quinazoline derivatives to explore novel DHFR inhibitors.
Hadni H; Bakhouch M; Elhallaoui M
J Biomol Struct Dyn; 2023 Jan; 41(1):161-175. PubMed ID: 34825630
[TBL] [Abstract][Full Text] [Related]
4. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.
Adane L; Patel DS; Bharatam PV
Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504
[TBL] [Abstract][Full Text] [Related]
5. Antifolate Agents Against Wild and Mutant Strains of Plasmodium falciparum.
Shaikh MS; Rana J; Gaikwad D; Leartsakulpanich U; Ambre PK; Pissurlenkar RR; Coutinho EC
Indian J Pharm Sci; 2014 Mar; 76(2):116-24. PubMed ID: 24843184
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking Analysis of Pyrimethamine Derivatives with Plasmodium falciparum Dihydrofolate Reductase.
Singh IV; Mishra S
Bioinformation; 2018; 14(5):232-235. PubMed ID: 30108420
[TBL] [Abstract][Full Text] [Related]
7. Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors.
Ojha PK; Roy K
Med Chem; 2011 May; 7(3):173-99. PubMed ID: 21486210
[TBL] [Abstract][Full Text] [Related]
8. In silico screening, synthesis, and antimalarial evaluation of PABA substituted 1,3,5-triazine derivatives as Pf-DHFR inhibitors.
Saha A; Choudhury AAK; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Singh UP; Bhat HR
Exp Parasitol; 2023 Jul; 250():108546. PubMed ID: 37196703
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS.
Sahu S; Ghosh SK; Kalita J; Dutta M; Bhat HR
Exp Parasitol; 2016 Apr; 163():38-45. PubMed ID: 26821296
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and antimalarial evaluation of hybrid
Saha A; Choudhury AAK; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Pratap Singh U; Bhat HR
J Biomol Struct Dyn; 2023; 41(24):15520-15534. PubMed ID: 37154740
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives.
Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP
Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives.
Bhat HR; Singh UP; Thakur A; Kumar Ghosh S; Gogoi K; Prakash A; Singh RK
Exp Parasitol; 2015 Oct; 157():59-67. PubMed ID: 26164360
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship and comparative docking studies for cycloguanil analogs as PfDHFR-TS inhibitors.
Sivaprakasam P; Tosso PN; Doerksen RJ
J Chem Inf Model; 2009 Jul; 49(7):1787-96. PubMed ID: 19588935
[TBL] [Abstract][Full Text] [Related]
15. Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study.
Adhikari N; Choudhury AAK; Shakya A; Ghosh SK; Patgiri SJ; Singh UP; Bhat HR
J Biochem Mol Toxicol; 2023 Apr; 37(4):e23290. PubMed ID: 36541419
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of antimalarial activity of new derivatives of 2,4,6-s-triazine.
Pathak M; Ojha H; Tiwari AK; Sharma D; Saini M; Kakkar R
Chem Cent J; 2017 Dec; 11(1):132. PubMed ID: 29256159
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase.
Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R
Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: a novel and potential antifolate lead for Pf-DHFR-TS inhibition.
Gahtori P; Ghosh SK; Parida P; Prakash A; Gogoi K; Bhat HR; Singh UP
Exp Parasitol; 2012 Mar; 130(3):292-9. PubMed ID: 22233734
[TBL] [Abstract][Full Text] [Related]
19. Microwave-assisted synthesis of hybrid PABA-1,3,5-triazine derivatives as an antimalarial agent.
Kashyap A; Choudhury AAK; Saha A; Adhikari N; Ghosh SK; Shakya A; Patgiri SJ; Bhattacharyya DR; Singh UP; Bhat HR
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22860. PubMed ID: 34313355
[TBL] [Abstract][Full Text] [Related]
20. Identification of the optimal third generation antifolate against P. falciparum and P. vivax.
Hunt SY; Detering C; Varani G; Jacobus DP; Schiehser GA; Shieh HM; Nevchas I; Terpinski J; Sibley CH
Mol Biochem Parasitol; 2005 Dec; 144(2):198-205. PubMed ID: 16181688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
